PeakedLabs Clinical Education Series · Digital guide
Know what to ask, test, and pay before you start peptide therapy.
Peptide outcomes are front-loaded in marketing and back-loaded in risk. This guide reverses that: baseline labs before first dose, conservative titration with predefined stop rules, and real monthly cost math across branded, compounded, and gray-market channels.
- Length
- 36 pages, 7 chapters
- Format
- PDF, instant download
- Edition
- March 2026
One-time purchase. Secure checkout via Stripe.
What's inside
Seven chapters, one decision system
Read in order or jump straight to the worksheets: the guide is built to be carried into a clinician appointment, not just read once.
- 01
How Peptide Therapy Actually Works
Mechanism of action from receptor binding to system effects, the GH/IGF-1 and melanocortin signaling pathways, the U.S. regulatory landscape as of 2026, and why real-world results vary so much between people on identical protocols.
- 02
Comparing the Most-Used Peptides by Goal
A quick comparison matrix, then goal-by-goal analysis: recovery (BPC-157, TB-500), body composition (CJC-1295/Ipamorelin, tesamorelin, AOD-9604), sleep (DSIP, epitalon), sexual health (PT-141), and longevity (GHK-Cu) — ending in a consolidated dose, duration, and outcome table.
- 03
Lab Markers to Baseline Before Starting
The core baseline panel, why each marker matters, typical adult reference ranges, baseline timing and repeat schedules, testing-service options, and the red-flag lab patterns to fix before starting anything.
- 04
Dosing Frameworks and Titration Strategy
A four-phase dosing framework, cycling strategy, reconstitution fundamentals, safety-focused injection technique, non-negotiable stop rules, and a practical titration worksheet to bring to your clinician visit.
- 05
Side Effects, Warning Signs, and Mitigation
Common side effects by peptide group, red flags that require same-day medical contact, a symptom-to-action table, when to seek emergency care, and psychological and behavioral risk.
- 06
Cost Breakdowns and Sourcing Due Diligence
Price reality across branded prescriptions, compounded clinics, and research-chemical listings; a sample monthly cost model; a quality-verification checklist; and the red flags of unsafe sourcing.
- 07
How to Review Options with Your Clinician
Questions to ask, a clinician-ready decision grid, how to find peptide-knowledgeable clinicians, a shared-decision template, and a final pre-start checklist. Closes with full references.
36 pages · 7 chapters · one-time purchase, instant download.
From Chapter 4 · Dosing Frameworks and Titration Strategy
“A good protocol is not ‘how high can dose go.’ It is ‘how early can risk be detected and how clearly can benefit be measured.’”
Sample excerpt: the non-negotiable stop rules
Every protocol in the guide is paired with stop criteria you define before the first dose. This list is from section 4.8 — stop immediately and contact your clinician for any of these:
- Persistent blood-pressure elevation
- Severe nausea or vomiting with dehydration
- Progressive edema, dyspnea, or chest pain
- Neurologic symptoms: severe headache, focal deficits, syncope
- Signs of allergic reaction
- Rapid glucose deterioration
Buy it if
This guide earns its price when
- You are evaluating peptide therapy with a licensed clinician and want the homework done before the consultation.
- You are already on a protocol and want tighter monitoring: which labs, on what schedule, and what symptoms mean stop.
- You are comparing clinics and want to pressure-test their pricing, lab requirements, and refill terms with specific questions.
Skip it if
Save your $29 when
- You want sourcing shortcuts for research chemicals without clinician oversight. The guide argues directly against that.
- You want a promise of results. The evidence for several popular peptides is preclinical or mixed, and the guide says so compound by compound.
- You are a clinician looking for a primary-literature review. This is a structured decision guide for patients, with references — not a meta-analysis.
Questions
Before you buy
- Price
- $29, one-time
- Format
- 36-page PDF
- Delivery
- Instant PDF download
- Edition
- March 4, 2026
Is this medical advice?
No. The guide is educational and opens with its own medical disclaimer. It exists to help you prepare better questions, labs, and stop rules for a conversation with a licensed clinician — not to replace one.
Which peptides does it actually cover?
BPC-157, TB-500, CJC-1295/Ipamorelin, tesamorelin, AOD-9604, DSIP, epitalon, PT-141 (bremelanotide), and GHK-Cu — organized by goal (recovery, body composition, sleep, sexual health, longevity) rather than by hype.
Does it cover GLP-1s like semaglutide?
No. The guide focuses on the peptide categories above. Our GLP-1 coverage — providers, pricing, and muscle-loss tradeoffs — is free on the blog.
I'm already on a protocol. Is it still useful?
Chapters 3 through 5 are written for exactly that case: baseline and repeat lab schedules, a symptom-to-action table, and predefined stop rules you can adopt mid-protocol.
How is this different from your free articles?
The blog compares providers and covers single topics. The guide is one continuous decision system: comparison matrix, lab panel, titration worksheet, cost model, and clinician decision grid in a single document you can annotate and bring to an appointment.
How do I get it, and how current is it?
Checkout runs through Stripe, and your download link appears immediately after payment. The current edition is dated March 4, 2026, including the FDA regulatory status discussion as of that date.
The newsletter
Not ready to buy yet?
Get the free weekly research brief instead — peptide and TRT protocols, cost breakdowns, and provider quality updates.
Free forever. Unsubscribe anytime. We never sell your email.
Thirty-six pages of homework, so nothing in your protocol takes you by surprise.
This guide is for educational purposes only and is not medical advice, diagnosis, or treatment. It does not establish a clinician-patient relationship. Several peptides discussed are not FDA-approved for general human use. Always review options with a licensed clinician who can evaluate your history, medications, labs, and risk profile.